CarpoNovum AB has a new board

March 22, 2023, a new Board was elected. We are happy to introduce the following members and welcome them to CarpoNovum:

Chairman of the Board: Otto Drakenberg is a Stockholm based CEO and Board Chairman with extensive experience leading complex transformations in a range of industry sectors such as consumer goods, retail, consumer service and technology. Otto is the chairman of the board of Spendrups Brewery, Svegro and SisjöIntressenter and was until 2022 Group CEO of Scandi Standard. His former operational roles include CEO of Carlsberg Sweden, Group CEO of the Nordic wine and liquor group Arcus, Chairman of the Board and leader of the reconstruction and sale of the retail chain Twilfit, Group CEO of Moment Group.

Boardmember: Lars Johansson Brings 30 years of experience from the medtech and pharmaceutical industry, including 13 years as General Manager for Johnson & Johnson in the Nordics. Lars has a track record of being an extraordinary leader and his experience covers all strategic and operational aspects of bringing innovative treatments to patients.

Boardmember: Björn Olsen Professor of Infectious Diseases since 2007 at Uppsala University and Academic Hospital. Olsen's scientific publication has (2020) according to Google Scholar over 15,000 citations and an h-index of 57. He is also an ornithologist and expert in bird-borne diseases, including bird flu. In the fall of 2010, he published the book Pandemic. Olsen was one of the 2020 summer host at one of the Swedish radio channels and the program aired on July 28, 2020.

Read more about CarpoNovum here.

CarpoNovum is a registered manufacturer in the UK

We are happy to announce that we have an AR in the UK!​

CarpoNovum AB is a registered manufacturer in the UK. This means that we are introducing our innovative anastomotic device on the Great Britain Market.​

The registration is made through the Medicines and Healthcare products Regulatory Agency, MHRA.​

We are currently building a clinical study program with prominent centers in the UK. If you are based in the UK and interested in learning more about our devices, participating in clinical studies, becoming a certified surgeon or other collaboration – Let us know!

Updated Advisory Board

As of November 2022, CarpoNovum AB has added further clinical and surgical expertise to our Advisory Board.​

The Clinical and Surgical Advisory Board members have experience and training from Karolinska in Stockholm, Odense University Hospital, St. Mark's Hospital in London, University Hospital of Leuven, Hôpital Cantonal in Geneva and Norrland University Hospital, among others. ​

Our Advisory Board members will be of great importance for product development, especially in close collaboration with new and ongoing clinical studies.​

We warmly welcome our new members joining the CarpoNovum team, as well as everyone staying on for this new, exciting year!​

More information about our Advisory Board can be found here